Suppr超能文献

初始类固醇反应对类固醇抵抗型肾病综合征患儿移植结局的影响。

Impact of initial steroid response on transplant outcomes in children with steroid-resistant nephrotic syndrome.

作者信息

Francis Anna, Prestidge Chanel, Kausman Joshua, Le Page Amelia, Larkins Nicholas, McCarthy Hugh

机构信息

Department of Nephrology, Queensland Children's Hospital, Brisbane, Australia.

Department of Nephrology, Starship Children's Hospital, Auckland, New Zealand.

出版信息

Pediatr Nephrol. 2022 May;37(5):1149-1156. doi: 10.1007/s00467-021-05270-x. Epub 2021 Oct 28.

Abstract

BACKGROUND

Limited data suggest children with secondary steroid-resistant nephrotic syndrome (secondary SRNS) have increased risk of recurrence post transplantation. There are no data on the association between secondary steroid resistance and risk of transplant loss.

METHODS

Children who received kidney transplantation between 2000 and 2019 for either primary or secondary SRNS in Australia and New Zealand were included. Children presenting with nephrotic syndrome before 12 months were excluded. Data were gathered from chart reviews and ANZDATA. Transplant survival was estimated using the Kaplan-Meier estimator with Cox modelling used to explore predictors of survival.

RESULTS

There were seventy children, 38 (55%) male, median age at presentation 4 years (IQR 2-7) and 46 (66%) Caucasian. Median age at transplant was 11 years (IQR 7-15) and 39 (55%) received living donor transplant. Secondary SRNS occurred in 20/70 (29%). For those with secondary SRNS, 18/20 (90%) had recurrence post-transplant, compared to 18/50 (36%) with primary SRNS (p = 0.001). Every child with history of atopy (n = 11) or with hypoalbuminaemia at time of transplant (n = 13) experienced immediate recurrence. For children with secondary SRNS, 8/18 (44%) with post-transplant recurrence had no response to therapy. For children with primary SRNS, 4/18 (22%) with recurrence had no response to therapy (p = 0.3). Overall, 10-year transplant survival was 47% (95%CI 29-77%) for those with secondary SRNS, compared to 71 (95%CI 57-88%) for those with primary SRNS (p = 0.05).

CONCLUSIONS

Secondary steroid resistance is strongly associated with SRNS recurrence. Atopy and hypoalbuminaemia at transplant may be novel risk factors for recurrence. Further research is needed to assess if secondary steroid resistance is associated with poorer transplant outcomes. "A higher resolution version of the Graphical abstract is available as Supplementary information".

摘要

背景

有限的数据表明,继发性类固醇抵抗性肾病综合征(继发性SRNS)患儿移植后复发风险增加。目前尚无关于继发性类固醇抵抗与移植失败风险之间关联的数据。

方法

纳入2000年至2019年间在澳大利亚和新西兰因原发性或继发性SRNS接受肾移植的儿童。排除12个月前出现肾病综合征的儿童。数据通过病历审查和澳大利亚及新西兰透析与移植登记处(ANZDATA)收集。使用Kaplan-Meier估计器估计移植存活率,并采用Cox模型探索生存预测因素。

结果

共有70名儿童,其中38名(55%)为男性,就诊时中位年龄为4岁(四分位间距2 - 7岁),46名(66%)为白种人。移植时中位年龄为11岁(四分位间距7 - 15岁),39名(55%)接受活体供体移植。继发性SRNS发生于20/70(29%)。对于继发性SRNS患儿,18/20(90%)移植后复发,而原发性SRNS患儿为18/50(36%)(p = 0.001)。每位有特应性病史(n = 11)或移植时低白蛋白血症(n = 13)的儿童均立即复发。对于继发性SRNS患儿,移植后复发的18例中有8例(44%)对治疗无反应。对于原发性SRNS患儿,复发的18例中有4例(22%)对治疗无反应(p = 0.3)。总体而言,继发性SRNS患儿10年移植存活率为47%(95%置信区间29 - 77%),原发性SRNS患儿为71%(95%置信区间57 - 88%)(p = 0.05)。

结论

继发性类固醇抵抗与SRNS复发密切相关。移植时的特应性和低白蛋白血症可能是复发的新危险因素。需要进一步研究以评估继发性类固醇抵抗是否与较差移植结局相关。“可获取更高分辨率的图形摘要作为补充信息”。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验